Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hepatitis
ADR ID BADD_A02019
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.07      Hepatocellular damage and hepatitis NEC
09.01.07.004      Hepatitis
Description INFLAMMATION of the LIVER. [MeSH]
MedDRA Code 10019717
MeSH ID D006505
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hepatitis | Hepatitis in other infectious diseases classified elsewhere | Hepatitis nonicteric | Hepatitis nonspecific | Hepatitis NOS | Hepatitis reactive non-specific | Hepatitis symptom | Hepatitis, unspecified | Nonspecific hepatitis | Hepatitis aggravated | Hepatitis non-icteric | Syncytial giant cell hepatitis | Hepatitis flare | Liver inflammation | Icteric hepatitis | Hepatitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01559Niacin0.000420%
BADD_D01562Nicorandil--
BADD_D01563Nicotinate--
BADD_D01566Nifedipine0.000164%
BADD_D01567Nilotinib0.000616%
BADD_D01569Nimodipine--
BADD_D01572Nitisinone0.004312%
BADD_D01576Nitrofurantoin--
BADD_D01577Nitrofurantoin (macrocrystals)--
BADD_D01578Nitrofurantoin (monohydrate/macrocrystals)--
BADD_D01581Nivolumab--
BADD_D01582Nizatidine--
BADD_D01585Norethindrone--
BADD_D01587Norfloxacin--
BADD_D01588Nortriptyline--
BADD_D01595Octreotide acetate--
BADD_D01598Ofloxacin--
BADD_D01599Olanzapine0.000989%
BADD_D01600Olanzapine pamoate--
BADD_D01601Olaparib0.000224%
BADD_D01602Olmesartan0.000210%
BADD_D01607Olsalazine--
BADD_D01608Olsalazine sodium--
BADD_D01614Omeprazole--
BADD_D01615Omeprazole magnesium--
BADD_D01624Orlistat0.011311%
BADD_D01627Oseltamivir--
BADD_D01628Oseltamivir phosphate--
BADD_D01629Osimertinib0.000974%
BADD_D01633Oxaliplatin0.001007%
The 14th Page    First    Pre   14 15 16 17 18    Next   Last    Total 21 Pages
ADReCS-Target
ADR Term Drug Name Target